CD4 and graft versus host disease: Therefore, the CD4+ T-cell response is significantly distinct at day+15 and day+25 in this GVHD model, with an initial inflammatory phase at day+15 followed by a pro-fibrotic cytokine production at day+25, characteristic of the chronic phase of GVHD.